Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
ADVISORY: Job Action to Begin Today at Edmonton and Area Schools
-
iRobot Announces Preliminary Fourth-Quarter 2024 Financial Results
-
The ONE Group Reports Preliminary Fourth Quarter and Full Year 2024 Sales Results
-
Comtech Announces CEO Transition and Comprehensive Transformation Initiatives
-
Aktion Associates Promotes Paul Prickett To Vice President of AES Division
-
Pulse Biosciences’ Nanosecond PFA Technology to be Featured in Multiple Presentations at the AF Symposium
-
ClearView Healthcare Partners Makes Strategic Investment in Epistemic AI to Advance Next-Generation Biomedical AI Platform
-
Numinus Provides Bi-Weekly Update on Annual Filings
-
Qventus Announces $105 Million Investment, Series D Led by KKR
-
Novocure Announces Preliminary Full Year and Fourth Quarter 2024 Performance and Provides Company Update
-
STRETCH ZONE CELEBRATES THE FIRST GRAND OPENING OF 2025 IN BURLINGTON, NORTH CAROLINA
-
Nu Skin Enterprises Announces Q4 Preliminary Revenue at High End of Guidance
-
DeGirum Delivers AI Hub to Accelerate Edge AI Development
-
STAAR Surgical to Host Fourth Quarter and Fiscal Year 2024 Earnings Conference Call and Webcast on February 19, 2025
-
Pelican Energy Partners Announces Acquisition of Lancs Industries
-
Schrödinger Provides Update on Progress Across the Business and Outlines 2025 Strategic Priorities
-
Oshkosh Defense Advances Next-Gen Autonomous Technology for ROGUE-Fires
-
Macy’s, Inc. Provides Fourth Quarter 2024 Update
-
Pelican Energy Partners Announces the Acquisition of Skolnik Industries
-
Porter Secures Sale and Leaseback with Avolon for Four Pratt & Whitney PW1921G Engines
-
CareDx Announces Preliminary Fourth Quarter and Full Year 2024 Results
-
TruFood and Bar Bakers Unite as Tandem Foods, Redefining Customer Partnership in the Better-For-You Snack Industry
-
Barrick Recommends Shareholders Reject TRC Capital’s Below-Market “Mini-Tender” Offer for Common Shares
-
CytoSorbents Strengthens Balance Sheet with Closing of Oversubscribed Rights Offering
-
Greenwich LifeSciences Partners with Unicancer Expanding Flamingo-01 into France
-
Bunker Hill Provides Project and Corporate Update
-
Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2025 Outlook
-
Aduro Clean Technologies to Ring the Nasdaq Closing Bell on Friday, January 17th, 2025
-
Axsome Therapeutics Provides Preliminary Fourth Quarter and Full Year 2024 Net Revenue
-
Akero Therapeutics Completes Enrollment of the Double-Blind Portion of the Phase 3 SYNCHRONY Real-World Study Evaluating Efruxifermin (EFX) in Patients with Non-Invasively Diagnosed MASH or MASLD
-
Five Below, Inc. Announces Holiday Sales Results for Quarter-To-Date Through January 4, 2025
-
Verve Therapeutics Announces Pipeline Progress and Anticipated 2025 Milestones
-
Smart Meter Remote Patient Monitoring Achieves Remarkable Growth and Expansion
-
ADMA Biologics Announces Preliminary Full Year 2024 Revenue and Provides Business Update
-
Abercrombie & Fitch Co. Increases Fourth Quarter and Full Year Net Sales Outlook on Better-Than-Expected Holiday Sales
-
Travere Therapeutics Provides Corporate Update and 2025 Outlook
-
Autolus Therapeutics Provides Business Updates and 2025 Overview
-
Destination XL Group, Inc. Reports Holiday Sales Results
-
Fractyl Health Announces Positive Initial Clinical Results Demonstrating Weight Maintenance Following GLP-1 Discontinuation and Revita Procedure in First Patient of the REVEAL-1 Cohort
-
Aquestive Therapeutics Provides Business Update and Outlines Key 2025 Objectives
-
Foghorn Therapeutics Highlights Program Progress and Strategic Objectives for 2025
-
Vera Therapeutics Acquires Global Rights to Novel, Next Generation Dual BAFF/APRIL Inhibitor
-
iBio Announces New Investments from Board Members and Officers
-
Braves Announce Exclusive Gray Media Spring Training Action
-
Beam Therapeutics Announces Progress in Hematology and Genetic Disease Franchises and Outlines Key 2025 Anticipated Catalysts
-
Oatly to Report Fourth Quarter 2024 Financial Results on February 12, 2025
-
Mastercard and FreedomPay Unlock Global Commerce With New Payment Gateway Partnership
-
Amphista Therapeutics appoints Paul Medeiros as Chief Business Officer
-
EDAP Announces Preliminary Record Fourth Quarter Focal One® System Sales and Record U.S. Procedures
-
ClearView Healthcare Partners Makes Strategic Investment in Epistemic AI to Advance Next-Generation Biomedical AI Platform
